Skip to main content
All lobbying filings

MILLER STRATEGIES, LLC

MILLER STRATEGIES, LLC filed a Q2 report for BRISTOL-MYERS SQUIBB COMPANY on July 20, 2026.

Lobbying for BRISTOL-MYERS SQUIBB COMPANY · Biopharmaceutical company

All filings by MILLER STRATEGIES, LLC · Everything BRISTOL-MYERS SQUIBB COMPANY has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey

Official filing document

 Lobbying activity 2

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem